| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| 3-Mercaptopropionyl-Tyr-D-Trp-Lys-Val-Cys-Phe-NH2 |
3-MERCAPTOPROPIONYL-TYR-D-TRP-LYS-VAL-CYS-PHE-NH2 |
|
詳細(xì)
|
| 4A/4B, 5A/5B Peptide;Ac-DEMEECSMSY-NH2 |
AC-ASP-GLU-MET-GLU-GLU-CYS-SER-MET-SER-TYR-NH2 |
|
詳細(xì)
|
| 4A/4B Peptide (1);DEMEECSQHLPYI |
ASP-GLU-MET-GLU-GLU-CYS-SER-GLN-HIS-LEU-PRO-TYR-ILE |
|
詳細(xì)
|
| MMP Inhibitor 1 |
4-氨基苯甲?；?甘氨酰-脯氨酰-D-亮氨酰-D-丙氨酰異羥肟酸 |
124168-73-6 |
詳細(xì)
|
| 4B/5A Peptide;ECTTPCSGSWLRD |
GLU-CYS-THR-THR-PRO-CYS-SER-GLY-SER-TRP-LEU-ARG-ASP |
|
詳細(xì)
|
| 4-Biphenylac-Cys(Me)-D-Arg-Phe-(2-phenylethyl)amide |
4-BIPHENYLAC-CYS(ME)-D-ARG-PHE-(2-PHENYLETHYL)AMIDE |
478164-48-6 |
詳細(xì)
|
| 4-Fluoro-benzenesulfonyl-Val-Leu-aldehyde |
4-FLUORO-BENZENESULFONYL-VAL-LEU-ALDEHYDE |
190274-53-4 |
詳細(xì)
|
| 4-Methoxy-Bz-Pro-Phe-pNA |
4-METHOXY-BZ-PRO-PHE-PNA |
|
詳細(xì)
|
| 4-Methoxyphenylureido-Met-Leu-Phe-OH |
4-METHOXYPHENYLUREIDO-MET-LEU-PHE-OH |
|
詳細(xì)
|
| 4-Nitro-Z-Gly-Cys(7-nitro-benzo[2,1,3]oxadiazol-4-yl)-Gly-OH |
4-NITRO-Z-GLY-CYS(7-NITRO-BENZO[2,1,3]OXADIAZOL-4-YL)-GLY-OH |
152390-46-0 |
詳細(xì)
|
| 4-Nitro-Z-Gly-Trp-Gly-OH |
4-硝基-Z-GLY-TRP-GLY-OH |
64792-79-6 |
詳細(xì)
|
| 5-(H-Gly-Pro-Gly-Pro-amido)-9-[di-(3-sulfonylpropyl)amino]-benzo[a]phenoxazonium perchlorate |
5-(H-GLY-PRO-GLY-PRO-AMIDO)-9-[DI-(3-SULFONYLPROPYL)AMINO]-BENZO[A]PHENOXAZONIUM PERCHLORATE |
948896-68-2 |
詳細(xì)
|
| 5A/5B Peptide (1);EDVV-Abu-CSMSY |
GLU-ASP-VAL-VAL-ABU-CYS-SER-MET-SER-TYR |
|
詳細(xì)
|
| 5A/5B Peptide (3);Ac-EEVVAC-pNA |
AC-GLU-GLU-VAL-VAL-ALA-CYS-PNA |
389868-12-6 |
詳細(xì)
|
| 6-(7-Nitro-benzo[2,1,3]oxadiazol-4-ylamino)-hexanoyl-Arg-Pro-Lys-Pro-Leu-Ala-Nva-Trp-Lys(7-dimethylaminocoumarin-4-yl)-NH2 |
6-(7-NITRO-BENZO[2,1,3]OXADIAZOL-4-YLAMINO)-HEXANOYL-ARG-PRO-LYS-PRO-LEU-ALA-NVA-TRP-LYS(7-DIMETHYLAMINOCOUMARIN-4-YL)-NH2 |
945414-97-1 |
詳細(xì)
|
| 6-FAM-(Glu13·17·20)-Osteocalcin (1-46) (mouse) |
6-FAM-(GLU13·17·20)-OSTEOCALCIN (1-46) (MOUSE) |
|
詳細(xì)
|
| 6-FAM-AEEAc-Stichodactyla helianthus Neurotoxin (ShK) |
6-FAM-AEEAC-STICHODACTYLA HELIANTHUS NEUROTOXIN (SHK) |
1927927-42-1 |
詳細(xì)
|
| 6-TAMRA-Kemptide |
6-TAMRA-KEMPTIDE |
|
詳細(xì)
|
| 7-MCA-ARG-PRO-LYS-PRO-TYR-ALA-NVAL-TRP-MET-LYS (DNP)-NH2 |
7-MCA-ARG-PRO-LYS-PRO-TYR-ALA-NVAL-TRP-MET-LYS (DNP)-NH2 |
|
詳細(xì)
|
| 7-MCA-PRO-LEU-ALA-NVAL-DPA-ALA-ARG-NH2 |
7-MCA-PRO-LEU-ALA-NVAL-DPA-ALA-ARG-NH2 |
|
詳細(xì)
|
| 7-MCA-PRO-LEU-GLY-LEU-DPA-ALA-ARG-NH2 |
7-MCA-PRO-LEU-GLY-LEU-DPA-ALA-ARG-NH2 |
|
詳細(xì)
|
| A-18-F-NH2: Morphine Modulating Neuropeptide |
ALA-GLY-GLU-GLY-LEU-SER-SER-PRO-PHE-TRP-SER-LEU-ALA-ALA-PRO-GLN-ARG-PHE-NH2: AGEGLSSPFWSLAAPQRF-NH2 |
|
詳細(xì)
|
| 26S Proteasome Regulatory Subunit S5A (36-51) (human, mouse, rat) |
26S PROTEASOME REGULATORY SUBUNIT S5A (36-51) (HUMAN, MOUSE, RAT) |
|
詳細(xì)
|
| 2A/2B Dengue Protease Substrate??;Ac-RTSKKR-pNA |
AC-ARG-THR-SER-LYS-LYS-ARG- PNA |
|
詳細(xì)
|
| 2-Adamantanecarbonyl-Arg-Phe-NH2 |
RF9 |
876310-60-0 |
詳細(xì)
|
| 2B-(A);Biotin-RRAAEELDSRAGAPQL |
BIOTIN-ARG-ARG-ALA-ALA-GLU-GLU-LEU-ASP-SER-ARG-ALA-GLY-ALA-PRO-GLN-LEU |
|
詳細(xì)
|
| 2B-(pS) |
BIOTIN-ARG-ARG-ALA-ALA-GLU-GLU-LEU-ASP-SER-ARG-ALA-GLY-PSER-PRO-GLN-LEU |
|
詳細(xì)
|
| 2B-(S) |
BIOTIN-ARG-ARG-ALA-ALA-GLU-GLU-LEU-ASP-SER-ARG-ALA-GLY-SER-PRO-GLN-LEU |
|
詳細(xì)
|
| 2B/3, Dengue Protease Substrate??;Ac-EVKKQR-pNA |
AC-GLU-VAL-LYS-LYS-GLN-ARG- PNA |
|
詳細(xì)
|
| 2F5 epitope |
GLU-LEU-LEU-GLU-LEU-ASP-LYS-TRP-ALA-SER-LEU-TRP-ASN: ELLELDKWASLWN |
|
詳細(xì)
|
| 2-Furoyl-LIGRLO-NH2 Potent and Selective Protease-Activated Receptor 2 (PAR2) Agonist |
2-FUROYL-LEU-ILE-GLY-ARG-LEU-ORN-NH2 |
729589-58-6 |
詳細(xì)
|
| 3,5-Difluorophenylacetyl-Ala-Phg-OMe |
3,5-DIFLUOROPHENYLACETYL-ALA-PHG-OME |
208255-51-0 |
詳細(xì)
|
| 3/4A, Dengue Protease Substrate??;Ac-FAAGRK-pNA |
AC-PHE-ALA-ALA-GLY-ARG-LYS- PNA |
|
詳細(xì)
|
| 3-Mercaptopropionyl-Tyr-D-Trp-Lys-Val-Cys-p-chloro-D-Phe-NH2 |
3-MERCAPTOPROPIONYL-TYR-D-TRP-LYS-VAL-CYS-P-CHLORO-D-PHE-NH2 |
|
詳細(xì)
|
| [Gly1,Ser3,22,Gln4,34,Thr6,Ala19,Tyr21,Ala23,31, Aib32]-Pancreatic Polypeptide (human) |
GLY-PRO-SER-GLN-PRO-THR-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-ARG-TYR-ILE-ASN-MET-ALA-AIB-ARG-GLN-ARG-TYR-NH2 |
|
詳細(xì)
|
| [Gly11] Substance P |
ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-GLY-NH2 |
|
詳細(xì)
|
| [Gly22]-?-Amyloid (1-40) |
ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLY-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL |
|
詳細(xì)
|
| [His11]Substance P |
ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-HIS-NH2 |
|
詳細(xì)
|
| [His7] Corazonin |
GLP-THR-PHE-GLN-TYR-SER-HIS-GLY-TRP-THR-ASN-NH2: GLP-TFQYSHGWTN-NH2 |
|
詳細(xì)
|
| [Ile12, Val15] MUC5AC Analog 3 |
GLY-THR-THR-PRO-SER-PRO-VAL-PRO-THR-THR-SER-ILE-THR-SER-VAL-PRO |
|
詳細(xì)
|
| [Ile34]-β- Amyloid (25 - 34) |
GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-ILE |
|
詳細(xì)
|
| [Leu8] Renin Substrate Tetradecapeptide, rat |
ASP-ARG-VAL-TYR-ILE-HIS-PRO-LEU-HIS-LEU-LEU-TYR-TYR-SER |
|
詳細(xì)
|
| [Lys22] b-Amyloid: 1-40 |
ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-LYS-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL: DAEFRHDSGYEVHHQKLVFFAKDVGSNKGAIIGLMVGGVV |
|
詳細(xì)
|
| [Lys4] Sarafotoxin S6c |
CYS-THR-CYS-LYS-ASP-MET-THR-ASP-GLU-GLU-CYS-LEU-ASN-PHE-CYS-HIS-GLN-ASP-VAL-ILE-TRP (DISULFIDE BRIDGE: CYS1-CYS15, CYS3- CYS11) |
116495-45-5 |
詳細(xì)
|
| [Lys5, MeLeu9, NIe10]-Neurokinin A (4-10) |
ASP-LYS-PHE-VAL-GLY-LEU(N-ME)-NIE-NH2 |
|
詳細(xì)
|
| [Lys8] LH-RH |
GLP-HIS-TRP-SER-TYR-GLY-LEU-LYS-PRO-GLY-NH2: GLP-HWSYGLWPG-NH2 |
|
詳細(xì)
|
| [Lys8] Vasopressin Desglycinamide |
CYS-TYR-PHE-GLN-ASN-CYS-PRO-LYS |
|
詳細(xì)
|
| [MePhe8,Sar9] Substance P |
ARG-PRO-LYS-PRO-GLN-GLN-PHE-NMEPHE-SAR-LEU-MET-NH2 [RPKPQQF: NMEF-SAR-LM-NH2] |
|
詳細(xì)
|
| [Met5]-ENKEPHALIN-Arg-Gly-Leu |
[MET5]-ENKEPHALIN-ARG-GLY-LEU |
|
詳細(xì)
|
| [Met5]-ENKEPHALIN-Arg-Phe |
[MET5]-ENKEPHALIN-ARG-PHE |
100929-69-9 |
詳細(xì)
|
| [Nle35] b-Amyloid: 1-40? |
ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-NLE-VAL-GLY-GLY-VAL-VAL: DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL-NLE-VGGVV |
|
詳細(xì)
|
| [Nle4] a-MSH, amide |
AC-SER-TYR-SER-NLE-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL- NH2 |
|
詳細(xì)
|
| [Nle8] Pancreastatin, porcine |
GLY-TRP-PRO-GLN-ALA-PRO-ALA-NLE-ASP-GLY-ALA-GLY-LYS-THR-GLY-ALA-GLU-GLU-ALA-GLN-PRO-PRO-GLU-GLY-LYS-GLY-ALA-ARG-GLU-HIS-SER-ARG-GLN-GLU-GLU-GLU-GLU-GLU-THR-ALA-GLY-ALA-PRO-GLN-GLY-LEU-PHE-ARG-GLY-NH2: GWPQAPA-NLE-DGAGKTGAEEAQPPEGKGAREHSRQEEEETAGAPQGLFRG-N |
|
詳細(xì)
|
| [NMeTyr1] Dynorphin A: 1-13, amide, porcine |
NMETYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-PRO-LYS-LEU-LYS-NH2 [NMEY-GGFLRRIRPKLK-NH2] |
|
詳細(xì)
|
| MBP (4-14);QKRPSQRSKYL |
GLP-LYS-ARG-PRO-SER-GLN-ARG-SER-LYS-TYR-LEU: GLP-KRPSQRSKYL |
136132-68-8 |
詳細(xì)
|
| [Phe10] b-Amyloid: 1-40? |
ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-PHE-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL: DAEFRHDSGFEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
|
詳細(xì)
|
| [pNO2Phe7,Nle11] Substance P |
ARG-PRO-LYS-PRO-GLN-GLN-PHE: PNO2-PHE-GLY-LEU-NLE-NH2 [RPKPQQ-F: PNO2-FGL-NLE-NH2] |
|
詳細(xì)
|
| [Pro9]-Substance P;RPKPQQFFPLM-NH2 |
ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-PRO-LEU-MET- NH2 |
104486-69-3 |
詳細(xì)
|
| [pSer5]-Kemptide, Biotinylated;Biotin-LRRA-pS-LG |
BIOTIN-LEU-ARG-ARG-ALA-SER(PO3H2)-LEU-GLY |
|
詳細(xì)
|
| [Glu1] TRH |
GLU-HIS-PRO-NH2: EHP-NH2 |
|
詳細(xì)
|
| [Glu27] Protein Kinase C (19-36) |
ARG-PHE-ALA-ARG-LYS-GLY-ALA-LEU-GLU-GLN-LYS-ASN-VAL-HIS-GLU-VAL-LYS-ASN |
|
詳細(xì)
|
| Angiotensin (1-7);DRVYIHP |
A779 |
51833-78-4 |
詳細(xì)
|
| Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Leu |
ALA-ALA-ALA-TYR-GLY-GLY-PHE-LEU |
|
詳細(xì)
|
| α-Bag Cell Peptide (1-7);APRLRFY |
ALA-PRO-ARG-LEU-ARG-PHE-TYR |
|
詳細(xì)
|
| α-Bag Cell Peptide (1-8);APRLRFYS |
ALA-PRO-ARG-LEU-ARG-PHE-TYR-SER |
87549-53-9 |
詳細(xì)
|
| α-Bag Cell Peptide (1-9);APRLRFYSL |
ALA-PRO-ARG-LEU-ARG-PHE-TYR-SER-LEU |
87549-52-8 |
詳細(xì)
|
| Abl Cytosolic Substrate;EAIYAAPFAKKK |
GLU-ALA-ILE-TYR-ALA-ALA-PRO-PHE-ALA-LYS-LYS-LYS |
168202-46-8 |
詳細(xì)
|
| ABZ-(AMF)-SER-ARG-GLN-EDDNP |
ABZ-(AMF)-SER-ARG-GLN-EDDNP |
|
詳細(xì)
|
| Abz-(Asn670,Leu671)-Amyloid β/A4 Protein Precursor770 (669-674)-EDDnp |
ABZ-(ASN670,LEU671)-AMYLOID Β/A4 PROTEIN PRECURSOR770 (669-674)-EDDNP |
|
詳細(xì)
|
| Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide |
ABZ-ALA-GLY-LEU-ALA-P-NITROBENZYLAMIDE |
|
詳細(xì)
|
| Abz-Ala-Phe-Ala-Phe-Asp-Val-Phe-3-nitro-Tyr-Asp-OH |
ABZ-ALA-PHE-ALA-PHE-ASP-VAL-PHE-3-NITRO-TYR-ASP-OH |
143147-74-4 |
詳細(xì)
|
| Abz-Ala-Phe-Arg-Phe-Ser-Gln-EDDnp |
Abz-Ala-Phe-Arg-Phe-Ser-Gln-EDDnp |
1926163-28-1 |
詳細(xì)
|
| Abz-Amyloid β/A4 Protein Precursor770 (669-674)-EDDnp |
ABZ-AMYLOID Β/A4 PROTEIN PRECURSOR770 (669-674)-EDDNP |
|
詳細(xì)
|
| Abz-Amyloid β/A4 Protein Precursor770 (708-715)-Lys(Dnp)-D-Arg-D-Arg-D-Arg amide |
ABZ-AMYLOID Β/A4 PROTEIN PRECURSOR770 (708-715)-LYS(DNP)-D-ARG-D-ARG-D-ARG AMIDE |
|
詳細(xì)
|
| Furin Substrate |
ABZ-ARG-VAL-LYS-ARG-GLY-LEU-ALA-M-NITRO-TYR-ASP-OH |
174838-79-0 |
詳細(xì)
|
| Abz-Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Ser-3-nitro-Tyr-Thr-NH2 |
ABZ-ASP-ASP-ILE-VAL-PRO-CYS-SER-MET-SER-3-NITRO-TYR-THR-NH2 |
852572-93-1 |
詳細(xì)
|
| Abz-Gln-Val-Val-Ala-Gly-Ala-ethylenediamine-Dnp |
ABZ-GLN-VAL-VAL-ALA-GLY-ALA-ETHYLENEDIAMINE-DNP |
152390-52-8 |
詳細(xì)
|
| Abz-Glu-Ile-Phe-Val-Phe-Lys-Gln-ethylenediamine-Dnp |
ABZ-GLU-ILE-PHE-VAL-PHE-LYS-GLN-ETHYLENEDIAMINE-DNP |
848491-08-7 |
詳細(xì)
|
| Abz-Glu-Thr-Leu-Phe-Gln-Gly-Pro-Val-p-nitro-Phe-NH2 |
ABZ-GLU-THR-LEU-PHE-GLN-GLY-PRO-VAL-P-NITRO-PHE-NH2 |
396096-53-0 |
詳細(xì)
|
| Abz-Gly-Ala-Ala-Pro-Phe-3-nitro-Tyr-Asp-OH |
ABZ-GLY-ALA-ALA-PRO-PHE-3-NITRO-TYR-ASP-OH |
142689-23-4 |
詳細(xì)
|
| Abz-Gly-Ala-Lys(Ac)-Ala-Ala-Dap(Dnp)-NH2 |
ABZ-GLY-ALA-LYS(AC)-ALA-ALA-DAP(DNP)-NH2 |
761443-02-1 |
詳細(xì)
|
| (pY185)MAP (177-189) kinase??;DHTGFLTE-pY-VATR |
ASP-HIS-THR-GLY-PHE-LEU-THR-GLU-TYR(PO3H2)-VAL-ALA-THR-ARG |
|
詳細(xì)
|
| [Sar9] Substance P |
ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-SAR-LEU-MET-NH2 |
77128-75-7 |
詳細(xì)
|
| [Ser2]-Neuromedin C;GSHWAVGHLM-NH2 |
GLY-SER-HIS-TRP-ALA-VAL-GLY-HIS-LEU-MET-NH2 |
136058-54-3 |
詳細(xì)
|
| [Ser25]-PKC (19-36) Substrate;RFARKGSLRQKNVHEVKN |
ARG-PHE-ALA-ARG-LYS-GLY-SER-LEU-ARG-GLN-LYS-ASN-VAL-HIS-GLU-VAL-LYS-ASN |
113715-84-7 |
詳細(xì)
|
| [Thi5,8,DPhe7] Bradykinin |
ARG-PRO-PRO-GLY-THI-SER-DPHE-THI-ARG |
97825-07-5 |
詳細(xì)
|
| [Trp11] Neurotensin (8-13) |
ARG-ARG-PRO-TRP-ILE-LEU |
|
詳細(xì)
|
| [Trp7,Leu8] LH-RH, Free Acid |
GLP-HIS-TRP-SER-TYR-GLY-TRP-LEU-PRO-GLY: GLP-HWSYGWLPG |
|
詳細(xì)
|
| VIP Antagonist;KPRRPYTDNYTRLRKQMAVKKYLNSILN-NH2 |
AC-TYR-DPHE-ASP-ALA-ILE-PHE-THR-ASN-SER-TYR-ARG-LYS-VAL-LEU-GLY-GLN-LEU-SER-ALA-ARG-LYS-LEU-LEU-GLN-ASP-ILE-MET-SER-ARG-NH2 |
|
詳細(xì)
|
| [Tyr123] Prepro Endothelin (110-130), amide, human |
CYS-GLN-CYS-ALA-SER-GLN-LYS-ASP-LYS-LYS-TRP-SER-TYR-CYS-GLN-ALA-GLY-LYS-GLU-ILE-NH2 |
|
詳細(xì)
|
| [Tyr19] Diazepam-Binding Inhibitor Fragment |
GLN-ALA-THR-VAL-GLY-ASP-VAL-ASN-THR-ASP-ARG-PRO-GLY-LEU-LEU-ASP-LEU-LYS-TYR |
|
詳細(xì)
|
| [Tyr4]-MBP (1-11);Ac-ASQYRPSQRHG |
AC-ALA-SER-GLN-TYR-ARG-PRO-SER-GLN-ARG-HIS-GLY |
|
詳細(xì)
|
| [Tyr5] Bradykinin |
ARG-PRO-PRO-GLY-TYR-SER-PRO-PHE-ARG: RPPGYSPFR |
|
詳細(xì)
|
| [Tyr8,Nle11] Substance P |
ARG-PRO-LYS-PRO-GLN-GLN-PHE-TYR-GLY-LEU-NLE-NH2 |
|
詳細(xì)
|
| [Tyr9]- β-MSH (porcine): (Tyr49)-β-Lipotropin (41-58) (porcine) |
ASP-GLU-GLY-PRO-TYR-LYS-MET-GLU-TYR-PHE-ARG-TRP-GLY-SER-PRO-PRO-LYS-ASP |
198281-81-1 |
詳細(xì)
|
| [Val35] -β - Amyloid (1 - 42) |
ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-VAL-VAL-GLY-GLY-VAL-VAL-ILE-ALA |
|
詳細(xì)
|
| [Val5] Angiotensin I, human |
2-羥基-3-羧基苯并咔唑 |
484-43-5 |
詳細(xì)
|
| [Val8] Renin Substrate Tetradecapeptide, rat |
ASP-ARG-VAL-TYR-ILE-HIS-PRO-VAL-HIS-LEU-LEU-TYR-TYR-SER: DRVYIHPVHLLYYS |
|
詳細(xì)
|
| 360 MMP FRET Substrate III;Dnp-Pro-Leu-Gly-Met-Trp-Ser-Arg-OH |
熒光底物肽MMP-2/MMP-9 Fluorogenic Substrate I |
135662-07-6 |
詳細(xì)
|
| 26Rfa, Hypothalamic Peptide, rat??NEW;ASGPLGTLAEELSSYSRRKGGFSFRF-NH2 |
ALA-SER-GLY-PRO-LEU-GLY-THR-LEU-ALA-GLU-GLU-LEU-SER-SER-TYR-SER-ARG-ARG-LYS-GLY-GLY-PHE-SER-PHE-ARG-PHE-NH2 |
|
詳細(xì)
|